Robert Andrew Douglas

CIK 1352232 · Special Advisor · last filed 2026-01-23

Robert Andrew Douglas is a Special Advisor who has filed 163 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for GMED, was dated Jan 23, 2026. Across all open-market trades the lifetime net is −$65.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $60.8M across reported positions. 161 SEC filings were submitted jointly with RESMED INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$60.81M

Companies

2

Total Filings

163

Lifetime Open-Market Net

-$65.59M

Filer Profile

Reported Address
21 ATTUNGA ROAD
NEWPORT
Related Filers
RESMED INC — 161 joint filings, latest 2024-01-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GMED Director 2,005 $74.69 $149.8K $99.8K 10 2026-01-23
RMD Special Advisor 264,375 $229.44 $60.66M -$65.69M 148 2024-01-03

Recent Filings

163 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-01-23 GMED Grant (A) $0 EDGAR
2025-03-28 GMED Grant (A) $0 EDGAR
2024-01-30 GMED Grant (A) $0 EDGAR
2024-01-03 RMD $0 EDGAR
2023-11-20 RMD Tax (F) −1,375 -$204.8K EDGAR
2023-11-15 RMD Tax (F) −1,704 -$244.7K EDGAR
2023-08-16 RMD Sell (S) −1,500 -$271.5K EDGAR
2023-08-15 RMD Notice (144) −1,500 -$271.5K EDGAR
2023-07-18 RMD Sell (S) −1,500 -$333.3K EDGAR
2023-07-17 RMD Notice (144) −1,500 -$333.3K EDGAR
Showing 110 of 163
Page 1 of 17
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.